We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+5.28%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.8B
AUM Growth
+$1.26B
(+7.6%)
Cap. Flow
+$567M
Cap. Flow
% of AUM
3.2%
Top 10 Holdings %
Top 10 Hldgs %
11.28%
Holding
2,904
New
221
Increased
694
Reduced
820
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$82.7M |
| 2 |
PepsiCo
PEP
|
+$76.8M |
| 3 |
Marriott International
MAR
|
+$64.8M |
| 4 |
Tyson Foods
TSN
|
+$62.8M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$52.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$64.8M |
| 2 |
Hormel Foods
HRL
|
+$61.4M |
| 3 |
Gilead Sciences
GILD
|
+$59.9M |
| 4 |
Hilton Worldwide
HLT
|
+$54.7M |
| 5 |
TechnipFMC
FTI
|
+$51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.87% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 11.71% |
| 4 | Industrials | 10.79% |
| 5 | Consumer Discretionary | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Quest Diagnostics
DGX
$25.1B
| $12.9M | 0.07% |
152,194
+14,463
| +11% | +$1.21M |
|
327
Chesapeake Utilities
CPK
$3.26B
| $12.8M | 0.07% |
209,870
-6,768
| -3% | -$434K |
|
|
NVO
328
Novo Nordisk
NVO
$216B
| $12.8M | 0.07% |
614,864
-94,702
| -13% | -$2.35M |
|
329
Gartner
IT
$9.41B
| $12.6M | 0.07% |
142,840
-1,692
| -1% | -$159K |
|
|
BRCD
330
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $12.3M | 0.07% |
1,329,156
-154,987
| -10% | -$1.44M |
|
|
PDCO
331
DELISTED
Patterson Companies, Inc.
PDCO
| $12.1M | 0.07% |
262,672
+1,377
| +0.5% | +$65.1K |
|
332
Cardinal Health
CAH
$53.4B
| $12M | 0.07% |
153,818
-501,052
| -77% | -$40.5M |
|
|
AHT
333
Ashford Hospitality Trust
AHT
$21M
| $11.7M | 0.07% |
2,007
-219
| -10% | -$1.34M |
|
334
Berkshire Hathaway Class A
BRK.A
$1.07T
| $11.7M | 0.07% |
54
+2
| +4% | +$439K |
|
335
UGI
UGI
$8B
| $11.4M | 0.06% |
253,087
+204,755
| +424% | +$9.35M |
|
336
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
| $11.4M | 0.06% |
322,134
-15,140
| -4% | -$519K |
|
337
IQVIA
IQV
$34.7B
| $11M | 0.06% |
135,985
-72,781
| -35% | -$5.51M |
|
338
Invesco FTSE RAFI US 1000 ETF
PRF
$9.73B
| $10.9M | 0.06% |
579,890
-10,440
| -2% | -$195K |
|
339
Amazon
AMZN
$2.5T
| $10.8M | 0.06% |
257,960
-560
| -0.2% | -$21.4K |
|
340
TE Connectivity
TEL
$58.8B
| $10.7M | 0.06% |
166,537
+4,754
| +3% | +$291K |
|
341
RenaissanceRe
RNR
$13.7B
| $10.1M | 0.06% |
84,055
-1,000
| -1% | -$118K |
|
342
Lamar Advertising Co
LAMR
$16.2B
| $10M | 0.06% |
153,602
+4,441
| +3% | +$287K |
|
343
SPDR Gold Trust
GLD
$131B
| $10M | 0.06% |
79,641
+2,171
| +3% | +$277K |
|
344
MaxLinear
MXL
$6.49B
| $9.82M | 0.06% |
+484,491
| New | +$9.52M |
|
345
American Electric Power
AEP
$73.7B
| $9.79M | 0.06% |
152,452
-9,832
| -6% | -$661K |
|
|
WFM
346
DELISTED
Whole Foods Market Inc
WFM
| $9.75M | 0.05% |
344,060
+247,549
| +256% | +$7.62M |
|
347
Franklin Resources
BEN
$16.9B
| $9.54M | 0.05% |
268,129
-3,864
| -1% | -$137K |
|
348
Ralph Lauren
RL
$22.2B
| $9.52M | 0.05% |
94,100
-7,923
| -8% | -$796K |
|
|
SCG
349
DELISTED
Scana
SCG
| $9.4M | 0.05% |
129,975
-382,029
| -75% | -$27.9M |
|
350
Ametek
AME
$55.5B
| $9.28M | 0.05% |
194,214
+193,614
| +32,269% | +$9.22M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2016 Portfolio in Review
As of Q3 2016, Glenmede Trust held 2,904 positions worth $17.8B, up 7.6% from $16.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Glenmede Trust deployed $567M of net new capital in Q3 2016, opening 221 new positions and adding to 694 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Starbucks, an estimated $64.8M trimmed.
- Glenmede Trust's largest Q3 2016 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
- Glenmede Trust added most to McKesson in Q3 2016, an estimated $82.7M increase.
- Glenmede Trust's biggest Q3 2016 reduction was Starbucks, cutting an estimated $64.8M.
- Glenmede Trust fully exited WILSHIRE BANCORP INC in Q3 2016, selling an estimated $18.5M.
- Glenmede Trust's ten largest holdings make up 11% of its $17.8B portfolio in Q3 2016.
- Glenmede Trust opened 221 new positions and closed 148 in Q3 2016.
- Glenmede Trust's portfolio value rose 7.6% quarter-over-quarter to $17.8B.
Based on Glenmede Trust's 13F filing for Q3 2016, filed 14 Nov 2016.